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OBJECTIVES The purpose of this study was to determine long-term outcome in adults with congenitally
corrected transposition of the great arteries (CCTGA), with particular emphasis on systemic
ventricular dysfunction and congestive heart failure (CHF).
BACKGROUND Patients with CCTGA have the anatomical right ventricle as their systemic pumping
chamber, with ventricular dysfunction and CHF being relatively common in older adults.
METHODS Retrospective analysis of records of 182 patients from 19 institutions were reviewed to
determine current status and possible risk factors for systemic ventricular dysfunction and
CHF. Factors considered included age, gender, associated cardiac defects, operative history,
heart block, arrhythmias and tricuspid (i.e., systemic atrioventricular) regurgitation (TR).
RESULTS Both CHF and systemic ventricular dysfunction were common in groups with or without
associated cardiac lesions. By age 45, 67% of patients with associated lesions had CHF, and
25% of patients without associated lesions had this complication. The rates of systemic
ventricular dysfunction and CHF were higher with increasing age, the presence of significant
associated cardiac lesions, history of arrhythmia, pacemaker implantation, prior surgery of any
type, and particularly with tricuspid valvuloplasty or replacement. Aortic regurgitation (a
previously unreported problem) was also relatively common in this patient population.
CONCLUSIONS Patients with CCTGA are increasingly subject to CHF with advancing age; this complication
is extremely common by the fourth and fifth decades. Tricuspid (systemic atrioventricular)
valvular regurgitation is strongly associated with RV (anatomical right ventricle connected to
aorta in CCTGA patients; systemic ventricle in CCTGA) dysfunction and CHF; whether it
is causative or a secondary complication remains speculative. (J Am Coll Cardiol 2000;36:
255–61) © 2000 by the American College of Cardiology
In congenitally corrected transposition of the great arteries
(CCTGA), dysfunction of the systemic right ventricle
occurs with increasing frequency in older patients (1–4).
The factors contributing to this problem are poorly under-
stood. Indeed, there are patients with uncomplicated
CCTGA whose right ventricles appear to function nor-
mally, well into late adulthood (5–12). Surgical intervention
for associated lesions has been associated recently with
prolonged adult survival. Various potential risk factors for
systemic ventricular failure in CCTGA have been impli-
cated, including systemic atrioventricular valvular regurgita-
tion (tricuspid regurgitation [TR]) (3,4,13,14), associated
congenital cardiac defects (15,16), complete heart block
(17), and surgical intervention, particularly open heart
operations (18–20). The rarity of this condition has con-
tributed to limited experience at any single institution, and
published reports therefore contain relatively small numbers
of patients. Accordingly, the Project Committee of the
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International Society of Adult Congenital Cardiac Disease
undertook a multicenter retrospective review to determine
the prevalence of congestive heart failure (CHF) and right
ventricular dysfunction in CCTGA as a function of age, and
the probable risk factors associated with this problem.
METHODS
All members of the International Society for Adult Con-
genital Cardiac Disease were invited to include patients
fulfilling entry criteria in the study by filling out a patient
data form and sending it to the coordinating center by
October 27, 1997. In centers where an institutional review
board required approval for the study, it was obtained. Most
institutions reported exemption from this requirement be-
cause no patient names or identifying numbers were made
known to the data coordinating center at Vanderbilt Uni-
versity Medical Center. The criteria for inclusion or exclu-
sion from the study are shown in Table 1. There were 182
patients from 19 institutions enrolled. The institution phy-
sician director and number of patients from each institution
are indicated in Table 2. Not all institutions had a robust
database to ensure capture of all adult congenital heart
disease patient encounters. Each physician director, how-
ever, provided a careful search of his own database to ensure
as complete a CCTGA population capture as possible.
Because CCTGA is such an unusual diagnosis, it is our
hypothesis that most patients would be included in this
review.
These chart reviews were performed without any patient
being identified except by number. The study was in compli-
ance with each institution’s human studies committee.
Patients were classified into two groups. Group I in-
cluded 132 patients with significant associated lesions. This
group included patients with any of the following lesions:
large ventricular septal defect (VSD), moderate or severe
pulmonary stenosis (PS), pulmonary atresia, moderate or
severe TR and Ebstein-like anomaly of the tricuspid valve.
Group II consisted of 50 patients with minor or no
significant lesions (see Table 3). The VSD size was esti-
mated clinically and by echocardiography.
Pulmonary stenosis was classified as mild if catheteriza-
tion or Doppler estimates indicated a peak systolic gradient
of ,35 mm Hg. Estimation of TR was by Doppler study in
most patients, with the following guidelines for investiga-
tors: mild, no RV (anatomical right ventricle connected to
aorta in CCTGA patients; systemic ventricle in CCTGA)
enlargement, TR jet ,5 cm2; moderate, RV enlargement,
Abbreviations and Acronyms
AR 5 aortic regurgitation
CCTGA 5 congenitally corrected transposition of the
great arteries
CHF 5 congestive heart failure
LA 5 left atrium
LV 5 anatomical left ventricle connected to
pulmonary artery in CCTGA patients
PS 5 pulmonary stenosis
RV 5 anatomical right ventricle connected to
aorta in CCTGA patients; systemic
ventricle in CCTGA
TR 5 tricuspid regurgitation (right ventricular/
atrioventricular regurgitation)
VSD 5 ventricular septal defect
Table 1. Criteria for Inclusion in the Study
I. Age $18 years at time of entry into study or at time of death or
transplant.
II. Diagnosis: CCTGA characterized by atrioventricular and ventriculo–
arterial discordance whereby the anatomical left ventricle supports
the pulmonary circulation and the anatomical right ventricle supports
the systemic circulation.
A. Associated lesions could include ventricular septal defect (VSD),
pulmonary stenosis (PS), pulmonary atresia (PA), abnormalities
of the tricuspid (systemic atrioventricular) valve including
tricuspid regurgitation with or without Ebstein-like
malformation, and double outlet right ventricle.
B. Associated lesions that excluded patients from the study included
hypoplastic right or left ventricle, single ventricle,
superior–inferior ventricles, and criss-cross atrioventricular
connections.
Table 2. Collaborating Institutions
Institution M.D. Director
No. of
Patients
Atlanta/Emory Dr. J. Sutherland 7
Cleveland Clinic Dr. D. Murphy 14
Columbia/Presbyterian Dr. Welton Gersony 6
Duke Dr. S. Sanders 7
Florida Dr. I. Gessner 9
Goteborg, Sweden Dr. M. Dellborg 4
Hannover, Germany Dr. H. Kaemmerer 15
Hershey, PA Dr. W. Davidson 5
Indiana Dr. R. Hurwitz 3
Kentucky Dr. J. Noonan 5
Loyola, Chicago Dr. F. Cetta 13
Mayo Clinic Dr. H. Connolly 22
Nebraska Dr. J. Kugler 4
Oregon Dr. C. Morris 8
Sydney, Australia Dr. D. Celermajer 2
UCSF Dr. E. Foster 5
UCLA Dr. J. Perloff 18
Vanderbilt Dr. T. Graham 25
Vienna, Austria Dr. H. Baumgartner 10
Table 3. Classification of Patient Groups
Group I. CCTGA with associated lesions (n 5 132)
A. Large VSD 68%
B. Pulmonary stenosis (PS)* 47%
C. Pulmonary atresia (PA) 8%
D. Moderate or severe tricuspid regurgitation (TR) 57%
E. Ebstein-like anomaly of tricuspid valve (82% have TR) 32%
Group II. CCTGA without associated significant lesions (n 5 50)
F. No associated lesions 16%
G. Small VSD 18%
H. Mild PS 14%
I. Mild TR 71%
*Includes patients with homograft stenosis.
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TR jet 5 to 8 cm2; severe, RV enlargement, TR jet 8 cm2 1
pulmonary vein reversal in systole. Angiographic estimates
of TR were used by a few investigators with these guide-
lines: mild, normal RV size, contrast fills 10% to 25% of left
atrium (LA), clears in 1 to 2 beats; moderate, definite RV
enlargement, contrast fills .25% of LA, fails to clear in 2
beats; severe, marked RV enlargement, contrast fills most of
LA (6 pulmonary veins), fails to clear in 3 beats.
In addition, investigators provided the following infor-
mation for each patient: operative history, occurrence of
heart block/pacemaker insertion, occurrence of significant
arrhythmia requiring treatment, estimate of mitral and
aortic regurgitation, latest chest film with cardiothoracic
ratio for cardiomegaly estimate, and right and left ventric-
ular function assessment (echocardiograph, angiogram,
magnetic resonance imaging, or radionuclide angiography
estimate as normal, or mild, moderate or severely de-
creased). In addition, evidence for clinical systemic ventric-
ular dysfunction (congestive heart failure, CHF) and date of
onset of CHF were provided. Data supporting the diagnosis
of CHF were cardiomegaly, pulmonary congestion, edema,
hepatomegaly, gallop rhythm, fatigue and digoxin/diuretic/
afterload reduction therapy. Finally, current functional clas-
sifications using the Warnes-Somerville ability index and
the Toronto classification were provided.
Warnes-Somerville Ability Index
Grade 1: Normal life; full-time work or school; can
manage pregnancy.
Grade 2: Able to do part-time work; life modified by
symptoms.
Grade 3: Unable to work; noticeable limitation of activ-
ities.
Grade 4: Extreme limitation; dependent; almost house-
bound.
Toronto Congenital Heart Disease Functional Class
Class 1: Asymptomatic.
Class 2: Symptoms are present but do not interfere with
normal activities.
Class 3: Symptoms interfere with some but not most
activities.
Class 4: Symptoms interfere with most if not all activi-
ties.
Statistical methods. Demographic and clinical variables
were summarized using mean 6 SD and proportions within
groups I (CCTGA with significant associated lesions) and
II (CCTGA with minor or no associated lesions). Differ-
ences between groups were assessed by Pearson’s chi-square,
the Fisher exact test, and the two-sided, two-sample t test.
The association of selected variables with clinical CHF, RV
dysfunction, and LV (anatomical left ventricle connected to
pulmonary artery in CCTGA patients) dysfunction was
assessed by calculating odds ratio (OR) estimates and 95%
confidence intervals. These estimates were combined over
both groups using the Mantel-Haenszel method in the
absence of statistically significant differences between
groups. Survival curves were generated using Kaplan-Meier
estimates, and differences in survival between groups were
assessed by the log-rank test. The statistical software pack-
ages S-PLUS and SAS were used. A p value ,0.05 was
considered statistically significant.
RESULTS
Table 4 shows statistical analysis and t-test analysis for
pertinent variables for the two groups. Patient ages were not
different between the two groups and averaged 32 6 13
years (range 18 to 75 years) for the entire group of 182
patients.
Clinical CHF. Clinical CHF was common and signifi-
cantly more common in patients with associated lesions,
51% versus 34%. Figure 1 shows that the probability of
freedom from CHF is clearly greater for group II versus
group I when this variable is assessed versus advancing age.
By age 45 years, 67% of patients in group I have CHF,
Table 4. Demographic and Clinical Variables by Patient Group
Group I
(Associated Lesions)
(n 5 132)
Group II
(No Associated Lesions)
(n 5 50) p Value
Age (yr, mean 6 SD) 32 6 12 34 6 15 NS
Gender 37% female 52% female NS
CHF 51% 34% 0.04
RV Dysfunction:
Any 70% 55% NS
Moderate or severe 39% 32% NS
TR:
Any 82% 85% NS
Moderate or severe 57% 40% NS
Pacemaker 45% 27% 0.04
Arrhythmia 47% 29% 0.04
Open heart surgery
(excludes transplant)
70% 15% 0.001
LV Dysfunction 25% 7% 0.014
AR 36% 25% NS
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whereas 25% of patients in group II, those patients with
only minor or no associated lesions, have this complication.
Systemic ventricular dysfunction and tricuspid regurgi-
tation. Right (systemic) ventricular dysfunction was com-
mon in both groups, 70% and 55%, as was TR, 82% and
84%. Neither of these conditions were significantly different
between groups (see Table 4).
Figure 2 shows the probability of freedom from moderate
or severe RV (systemic ventricular) dysfunction as a function
of age. There is a clear continuing increase in systemic
ventricular dysfunction with increasing age; by age 45 years,
56% of patients with associated lesions and 32% of patients
without significant associated lesions have this complica-
tion. Although group I patients did have a higher incidence
of RV dysfunction than group II patients at any age, the
probability curves were not statistically different (p 5 0.08).
The incidence of pacemaker therapy, significant arrhyth-
mia requiring treatment, and open heart surgery were all
significantly greater in group I patients than group II
patients (see Table 4).
Pulmonary ventricular dysfunction and AR. Pulmonary
(anatomical left ventricular) dysfunction was present in 25%
of patients in group I and only 7% in group II. Left
ventricular dysfunction also showed an increase in incidence
with increasing age (Fig. 3). By age 45 years, 20% of
patients in group I and 5% in group II had LV dysfunction.
Again, although LV dysfunction as a function of age was
more common in group I than group II patients, the
difference in probability curves was not significant (p 5
0.11).
Finally, aortic regurgitation (AR) was a relatively com-
mon finding in patient groups I and II, 36% and 25%, but
not significantly different between groups (Table 4).
Risk factors for CHF: Ventricular dysfunction. In an
attempt to determine potential correlates for all patients,
clinical CHF, RV dysfunction, and LV dysfunction, OR
estimates were calculated for possible risk factors (Table 5).
For clinical CHF, the strongest risk factors were tricuspid
valve surgery, TR, significant arrhythmia, history of any
open heart surgery, and pacemaker therapy. For RV dys-
function, these same risk factors are significant. In addition,
male gender appears to be a risk factor of borderline
significance.
For LV dysfunction, there were no clearly significant risk
factors as assessed by this method of OR estimates.
Functional classification. Despite the relatively high fre-
quency of objective CHF and/or ventricular dysfunction,
Figures 4 and 5 show estimates of the functional classifica-
tion in which most patients consider themselves, with none
or minimal symptoms when assessed in this manner.
DISCUSSION
Systemic ventricular dysfunction and CHF. The present
study is the largest multicenter attempt to review the clinical
Figure 1. Probability of freedom from CHF for group I (associated lesions)
and group II (no significant associated lesions) as a function of increasing
age (N 5 175 instead of 182 because it was unclear in 7 patients whether
they had clinical CHF).
Figure 2. Probability of freedom from moderate or severe RV dysfunction
as a function of increasing age. (N 5 168 because data were unavailable to
make this determination in 14 patients.)
Figure 3. Probability of freedom from mild, moderate, or severe left
ventricular dysfunction with increasing age (N 5 147 because data were
unavailable to make this determination in 35 patients).
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course of patients with a rare form of congenital heart
disease—congenitally corrected transposition of the great
arteries. These data clearly indicate the increasing incidence
of systemic ventricular dysfunction and clinical CHF with
increasing age in patients with CCTGA. In patients’ most
productive middle years, symptomatic CHF is extremely
common. In patients with significant associated defects and
prior open heart surgery, two thirds of patients have CHF
by age 45. This complication also is common in middle-
aged adults with CCTGA and no associated significant
lesions; by the fifth decade more than one-third developed
this symptom. This is the largest cohort reported with this
condition, and it clearly indicates the potentially tenuous
nature of the compensated systemic right ventricle.
TR. Although it appears that systemic atrioventricular
valve (tricuspid) regurgitation plays a role in the determi-
nation of RV dysfunction and CHF, it is extremely difficult
to estimate whether this abnormality plays a primary or a
secondary role. Prieto and associates (14) in a cohort of 40
patients with CCTGA found TR to be a major risk factor
for systemic ventricular dysfunction during a follow-up of 7
to 36 years (mean 20 years). These investigators considered
the valvular abnormality to precede or precipitate CHF in
most of their patients.
Do these patients develop TR because of systemic ven-
tricular dysfunction, or do they have TR, which hastens the
development of systemic ventricular dysfunction? It is prob-
able that each scenario can play a role in individual patients.
In addition, it is clear that open heart surgery (particularly
tricuspid valve surgery) is associated with an increased risk
of RV dysfunction and CHF—possibly related to an in-
crease in afterload and/or difficulty in myocardial protection
during surgery. Acar and associates (21) recently reported
serial echocardiographic data in 82 patients with CCTGA,
which indicated the marked dependence of TR on RV
loading conditions. Lundstrom and colleagues (18) sug-
gested that CCTGA patients with symptomatic CHF and
TR should have tricuspid valve replacement prior to signif-
icant RV dilation. We concur that early tricuspid valve
replacement may be useful for selected individuals with RV
dilation in an attempt to preserve ventricular function.
Systemic ventricular dysfunction: Associated variables.
It is also probable that with the occurrence of symptomatic
heart block and ventricular pacing (which can result in
discordant ventricular contraction), systemic ventricular
dysfunction worsens.
The factors associated with preserved systemic ventricular
function in some elderly patients are poorly understood.
Recently, Hornung and associates (22) showed myocardial
perfusion defects in five unoperated patients with CCTGA
studied by myocardial perfusion scanning. There was evi-
dence for reversible myocardial ischemia in four patients and
fixed defects indicating infarction in five. One interpretation
of these findings is that intermittent episodes of myocardial
ischemia occur in these patients at times of high oxygen
consumption (stress, exercise, hypertension). There could be
inadequate coronary flow to a markedly hypertrophied
systemic right ventricle supplied by a right coronary artery
system with limited ability to provide adequate perfusion
during the extremes of metabolic demands. Patients who
continue with good systolic function may have right coro-
nary artery systems that are more well developed and
Figure 4. Warnes-Somerville functional classification for both patient
groups. Figure 5. Toronto functional classification for both patient groups.
Table 5. Odds Ratio (OR) Estimates for Clinical CHF, RV Dysfunction, and LV Dysfunction
CHF RV Dysfunction* LV Dysfunction†
OR‡ 95% CI p Value OR‡ 95% CI p Value OR‡ 95% CI p Value
TV replacement or valvuloplasty§ 4.33 (1.69, 11.1) 0.001 3.63 (1.48, 8.87) 0.004 0.59 (0.18, 1.93) 0.38
TR* 3.42 (1.75, 6.67) 0.0003 2.54 (1.29, 5.00) 0.006 0.63 (0.26, 1.51) 0.31
Arrhythmia 2.37 (1.24, 4.51) 0.008 3.14 (1.58, 6.22) 0.0009 1.73 (0.72, 4.09) 0.21
Surgery (no transplant) 2.14 (1.06, 4.32) 0.03 2.54 (1.15, 5.58) 0.02 1.40 (0.54, 3.59) 0.47
Pacemaker 2.08 (1.08, 3.96) 0.03 2.05 (1.05, 4.01) 0.03 0.70 (0.28, 1.71) 0.43
Sex 1.58 (0.84, 2.95) 0.15 1.92 (0.99, 3.71) 0.05 0.99 (0.42, 2.32) 0.99
PA§ 1.42 (0.38, 5.32) 0.75 0.34 (0.07, 1.70) 0.31 1.46 (0.33, 6.29) 0.69
Only VSD closure (6PS repair)§ 0.77 (0.31, 1.88) 0.56 0.69 (0.27, 1.75) 0.43 1.22 (0.41, 3.55) 0.72
PS or PA 0.58 (0.29, 1.13) 0.11 0.39 (0.19, 0.80) 0.008 0.79 (0.33, 1.88) 0.60
PS 0.54 (0.27, 1.06) 0.07 0.51 (0.25, 1.02) 0.05 0.62 (0.25, 1.51) 0.29
VSD 0.49 (0.23, 0.99) 0.05 0.52 (0.24, 1.07) 0.08 2.31 (0.83, 6.37) 0.11
*Moderate or severe. †Mild, moderate, or severe. ‡Mantel-Haenszel OR estimate (combined over study groups I and II) except where noted. §Group I only.
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provide adequate myocardial perfusion at times of high
oxygen demand.
AR. The presence of AR in 25% to 36% of patients was an
unexpected finding that has not been reported previously. In
patients with large right to left intracardiac shunts due to
VSD and pulmonary outflow obstruction, the aorta would
be expected to dilate, a finding that could lead to this
complication. In the majority of patients, however, right-to
left shunting was not present, and thus could not account
for aortic dilation or AR. Unfortunately, we do not have
data quantifying aortic root size in any of our patients, and
bicuspid aortic valve was not reported in any of our 182
patients. Thus, the cause(s) of AR in CCTGA remains
undefined.
Left ventricular dysfunction. The finding of LV dysfunc-
tion in a number of patients limits the option of doing the
so-called double switch operation (23–29) or makes this an
option best entertained at a relatively young age before LV
dysfunction becomes a problem. Because this procedure is
most frequently applied in patients with a large VSD, it may
need to be considered as a first surgical option before the
potential detrimental effects of open heart surgery contrib-
ute to clinical CHF.
Study limitations. This study was limited by its retrospec-
tive analyses. In addition, patients with CCTGA associated
with ventricular dysfunction and CHF may be more likely
to be referred to regional centers and thus included in a
center’s database. This could theoretically lead to an over-
estimation of these complications. Because CCTGA is such
a rare condition, however, it is likely that most patients with
this condition will eventually get referred to a regional
center for adult congenital heart disease and be included in
a database. Finally, part of the data reported depend on
defining the function of the morphologic, subaortic right
ventricle. Current information indicates that the ejection
fraction values of both the subpulmonary and the subaortic
normal right ventricle are nearly the same or only slightly
less than the normal left ventricle (30–32).
Conclusions. In conclusion, systemic ventricular dysfunc-
tion and clinical CHF are extremely common in middle-
aged adults with CCTGA. Although some patients with
this congenital abnormality continue to do extremely well
beyond age 60, this circumstance is the exception rather
than the rule. Aggressive medical treatment with afterload
reduction would appear indicated for these patients with
ventricular enlargement and early symptoms. The benefits
of the prophylactic use of vasodilators is unproven, but
deserves study in an attempt to delay or prevent systemic
ventricular dysfunction.
In addition, earlier surgical management of these patients
before ventricular dysfunction becomes prominent should
be incorporated into management in an attempt to improve
long-term outcome. Patients with favorable anatomy, de-
pressed RV function, and normal LV function should be
considered for the double-switch operation by centers with
experience and expertise in this procedure. Multi-
institutional collaborative studies will be needed to clarify
the merit of each of these management strategies.
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